Where can I find the detailed financial results for Gilead Sciences for the period ending December 31, 2017?

The detailed financial results are located within the press release filed as Exhibit 99.1 to this 8-K filing. The 8-K itself primarily serves to furnish this press release.

What is the difference between GAAP and non-GAAP financial information mentioned in the filing?

GAAP (Generally Accepted Accounting Principles) are standard accounting rules. Non-GAAP financial measures are adjusted figures that management believes provide additional useful insights into the company's performance and are used for internal planning. The press release contains a reconciliation to help understand the differences between the two.

Is this 8-K filing considered 'filed' for regulatory purposes, like Section 18 of the Exchange Act?

No, according to the filing, the information in this Form 8-K and its exhibit shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933 or the Exchange Act.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on February 6, 2018, to announce its financial results for the fourth quarter and full year ended December 31, 2017. The report primarily serves to furnish the press release containing these results, which is provided as Exhibit 99.1. Investors should note that Gilead presented both GAAP and non-GAAP financial measures, with management emphasizing the utility of non-GAAP figures for operational and planning insights. The press release, detailing the company's performance for the periods ending December 31, 2017, is the core of this filing. While the 8-K itself does not contain detailed financial statements, it directs investors to the press release for comprehensive results and reconciliations between GAAP and non-GAAP figures. This filing is crucial for understanding Gilead's most recent financial condition and operational performance as reported by the company.

Key Highlights

1Gilead Sciences announced its financial results for Q4 and full year 2017 via an 8-K filing on February 6, 2018.
2The primary purpose of the 8-K filing is to furnish a press release (Exhibit 99.1) containing these financial results.
3The press release provides both GAAP and non-GAAP financial information for the reporting periods.
4Management believes non-GAAP financial measures offer valuable insights for investors and are used internally for planning.
5A reconciliation between GAAP and non-GAAP financial information is available in the press release.
6The filing directs investors to the press release for detailed financial performance and data.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Feb 6, 2018)

Summary

Key Highlights

Frequently Asked Questions